
Featured
Senolytics Enter Advanced Clinical Trials: Targeting Cellular Senescence for Longevity and Alzheimer's
Senolytic drugs like dasatinib and quercetin are entering advanced clinical trials in 2026, targeting senescent "zombie cells" to reduce systemic infl...
Read Full Story →
